LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

Two recent studies conducted by scientists at the University Health Network and the University of Toronto provide new evidence regarding the effects of lysergic acid diethylamide (LSD) on the brain.

Patients who participate in the MM-120 study at Segal Trials’ Center for Psychedelic and Cannabis Research in Miami Lakes will be dosed and observed in a room made to resemble more of a home than a ...

NORTH CHARLESTON, S.C. (WCIV) — A new clinical trial underway in the Lowcountry is drawing attention for its unconventional, and potentially groundbreaking, approach to treating anxiety. Researchers ...

According to new research, psychedelic-assisted therapy could be a surprisingly effective and long-lasting treatment for anxiety and depression-related symptoms. As detailed in a new study published ...

For a couple of freewheeling years, two young Harvard psychologists have carried on wide-ranging experiments with mind-altering drugs. At the university’s Center for Research in Personality, they sent ...

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. Lysergic acid ...

Psychedelics such as LSD and psilocybin from “magic mushrooms” have been proposed to ease depression. But the hallucination side effect makes these powerful drugs less ideal as therapeutics. Now, ...